Skip to main content

Together we are beating cancer

Donate now

Cancer News

Research and trials

Showing 12 out of 1694 results
A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025

A pill in a petri dish. The Pill is transparent but contains a compressed black sponge. There is a light blue thread attached to one end.
  • Science & Technology
  • Health & Medicine

Meet the capsule sponge

This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks. This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks.

by Amal Iman | In depth | 13 November 2025

13 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025

Squamous epithelial cells of human cervix under the microscope view.
  • Health & Medicine
  • Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 13 November 2025

13 November 2025

A computer generated image showing two DNA helices in shades of blue.

A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients. A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients.

by Amal Iman | News | 7 August 2025

7 August 2025

A computer graphic showing three researchers working in a lab. Above them are three white bubbles howing the bacteria in the gut microbiome, a 'drug made from a bug' and cancer cells being targeted by immune cells.

By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'. By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'.

by Helen Renshaw | Analysis | 22 July 2025

22 July 2025

A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix. We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix.

by Sophie Wedekind, Patrick Keely | News | 21 July 2025

21 July 2025

A breast cancer cell seen through an electron microscope.

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

by Amal Iman, Tim Gunn | News | 13 May 2025

13 May 2025

A microscope image of a bowel organoid.

Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently

by Henry Scowcroft | In depth | 9 May 2025

9 May 2025

A photo of Michelle Mitchell, Wes Streeting and Deborah's family members at the Crick

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

by Michelle Mitchell | Opinion | 23 April 2025

23 April 2025

A union jack and EU flag tied together

As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond

by Laura Williams | Analysis | 22 April 2025

22 April 2025

Microscopy image of a prostate tumour

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

by Cancer Research UK | In depth | 14 April 2025

14 April 2025